when the purpose of ovarian stimulation is oocyte retrieval for oocyte or embryo cryopreservation. This includes continuation of mycophenolate or methotrexate (MTX). There is an anticipated risk of uncontrolled disease from withdrawal of effective medication. However, there are no published data that directly address oocyte retrieval during treatment with most immunosuppressive or biologic therapies other than CYC. Fertility preservation in women with RMD treated with CYC. Although CYC is used